National Research Corporation (NRC)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
National Research Corporation (NRC) trades at $22.54 with AI Score 69/100 (Grade B+). National Research Corporation provides analytics and insights to enhance patient and employee experience in the healthcare sector. Market cap: $507.98M, Sector: Healthcare.
Price live · AI analysis from May 31, 2026Analyst Coverage for NRC: NRC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NRC against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
NRC: 3/7 perspectives are bullish. Dominant signal: Ken Griffin bearish.
How is this calculated? →National Research Corporation (NRC) Healthcare & Pipeline Overview
National Research Corporation delivers subscription-based analytics and insights to healthcare organizations in the U.S. and Canada, focusing on enhancing patient and employee experiences. Their solutions cover patient experience, employee engagement, and brand loyalty, providing actionable data for informed decision-making in a competitive healthcare landscape.
What Is the Investment Thesis for NRC?
National Research Corporation presents a compelling investment case driven by its established position in the healthcare analytics market. The company's subscription-based model provides recurring revenue and a degree of stability, evidenced by a gross margin of 55.9%. Growth catalysts include the increasing demand for patient experience data and employee engagement solutions within the healthcare industry. With a P/E ratio of 44.7 and a dividend yield of 2.87%, NRC offers a blend of growth and income potential. However, investors should be mindful of the company's relatively small market capitalization of $507.98M and the potential impact of competition within the healthcare information services sector.
Based on FMP financials and quantitative analysis
NRC Key Highlights
- Market Cap of $507.98M reflects its position as a smaller player in the healthcare analytics space.
- P/E ratio of 44.7 indicates a premium valuation, suggesting investor expectations of future growth.
- Gross Margin of 55.9% demonstrates efficient cost management and strong pricing power.
- Dividend Yield of 2.87% provides a steady income stream for investors.
- Beta of 0.34 suggests lower volatility compared to the overall market, potentially appealing to risk-averse investors.
Who Are NRC's Competitors?
NRC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| VHIBF Vitalhub Corp. | $5.13 | +2.60% | $324.52M | 63 |
| KSIOF Kneat.com, Inc. | $4.55 | -0.24% | $437.40M | 63 |
| OMDA Omada Health | $22.85 | +2.05% | $1.36B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NRC's Key Strengths?
- Established presence in the healthcare analytics market.
- Subscription-based revenue model provides stability.
- Focus on patient and employee experience is a growing area of importance.
- Diverse portfolio of solutions addressing various healthcare needs.
What Are NRC's Weaknesses?
- Relatively small market capitalization compared to larger competitors.
- High P/E ratio may indicate overvaluation.
- Dependence on the healthcare industry makes it susceptible to regulatory changes.
- Limited geographic diversification, primarily operating in the U.S. and Canada.
What Could Drive NRC Stock Higher?
- Increasing demand for patient experience data due to value-based care models.
- Growing emphasis on employee engagement within healthcare organizations.
- Potential partnerships with healthcare IT vendors to expand market reach.
What Are the Key Risks for NRC?
- Rich valuation — a P/E of 44.7 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Intense competition from larger and more established players in the healthcare analytics market.
- Changes in healthcare regulations and reimbursement models could impact demand for NRC's solutions.
- Economic downturn may reduce healthcare spending and affect client budgets.
- Rapid technological advancements may render existing solutions obsolete.
What Are the Growth Opportunities for NRC?
- Expansion of Health Risk Assessment Solutions: The market for health risk assessment solutions is growing as healthcare organizations focus on preventative care and population health management. NRC can capitalize on this trend by expanding its health risk assessment solutions to help clients segment populations, manage care for at-risk individuals, and enhance wellness programs. This expansion can drive revenue growth and strengthen NRC's position in the market. The timeline for realizing significant gains from this opportunity is estimated to be within the next 2-3 years.
- Increased Focus on Telehealth Analytics: As telehealth adoption continues to rise, there is a growing need for analytics solutions that can provide insights into telehealth patient experiences and outcomes. NRC can leverage its expertise in patient experience measurement to develop specialized analytics solutions for telehealth providers. This would allow healthcare organizations to optimize their telehealth services and improve patient satisfaction. The market size for telehealth analytics is projected to grow significantly over the next 5 years.
- Penetration into the Canadian Market: While NRC already operates in Canada, there is still significant room for growth in this market. By increasing its sales and marketing efforts in Canada, NRC can attract new clients and expand its market share. The Canadian healthcare system presents unique opportunities for NRC's solutions, particularly in the areas of patient experience and employee engagement. This expansion could yield positive results within the next 1-2 years.
- Development of AI-Powered Analytics: Integrating artificial intelligence (AI) into its analytics solutions can provide NRC with a competitive edge. AI can be used to automate data analysis, identify patterns and trends, and provide more personalized insights to healthcare organizations. By investing in AI development, NRC can enhance the value of its solutions and attract clients seeking advanced analytics capabilities. This initiative could start showing results in the next 3-4 years.
- Strategic Partnerships with Healthcare IT Vendors: Collaborating with other healthcare IT vendors can expand NRC's reach and integrate its solutions into existing healthcare workflows. By partnering with electronic health record (EHR) vendors, revenue cycle management companies, and other healthcare technology providers, NRC can offer its analytics solutions to a wider audience. These partnerships can create synergies and drive revenue growth for both NRC and its partners. Partnerships can be formed and implemented within the next year.
What Opportunities Does NRC Have?
- Expansion into new geographic markets.
- Development of new analytics solutions for emerging healthcare trends.
- Strategic partnerships with other healthcare IT vendors.
- Increased adoption of telehealth and remote patient monitoring.
What Threats Does NRC Face?
- Intense competition from larger and more established players.
- Rapid technological advancements may render existing solutions obsolete.
- Changes in healthcare regulations and reimbursement models.
- Economic downturn may reduce healthcare spending.
What Are NRC's Competitive Advantages?
- Established relationships with healthcare organizations.
- Proprietary data and analytics expertise.
- Subscription-based revenue model provides recurring income.
- Focus on specialized solutions for patient and employee experience.
What Does NRC Do?
Founded in 1981 and headquartered in Lincoln, Nebraska, National Research Corporation (NRC) provides analytics and insights to healthcare organizations, facilitating the measurement and enhancement of patient and employee experiences. The company operates primarily in the United States and Canada, offering a portfolio of subscription-based solutions that deliver actionable information and analysis. These solutions address mission-critical areas such as patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. NRC's offerings include market insights solutions, which track healthcare brand awareness, perception, and consistency. These solutions assess competitive differentiators and provide enhanced segmentation tools to evaluate community needs and behaviors through real-time competitive assessments. The company's experience solutions cover patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Furthermore, NRC provides health risk assessment solutions that enable clients to segment populations, manage care for at-risk individuals, enhance preventative care, and manage wellness programs. Transitions solutions help organizations identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction, and support safe care transitions. Additionally, NRC offers transparency solutions that allow healthcare organizations to share information and ensure content informs consumer decision-making, along with governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. NRC serves integrated health systems, post-acute providers, and payer organizations.
What Products and Services Does NRC Offer?
- Provide analytics and insights to healthcare organizations.
- Offer subscription-based solutions for measuring and enhancing patient experience.
- Offer subscription-based solutions for measuring and enhancing employee experience.
- Provide market insights solutions to track healthcare brand awareness and perception.
- Offer health risk assessment solutions to manage care for at-risk individuals.
- Provide transitions solutions to reduce readmissions and enhance patient satisfaction.
- Offer transparency solutions for healthcare organizations to share information.
- Offer governance solutions for not-for-profit hospital and health system boards.
How Does NRC Make Money?
- Subscription-based revenue from analytics and insights solutions.
- Focus on recurring revenue through long-term client relationships.
- Offer a portfolio of solutions addressing various aspects of patient and employee experience.
- Serve integrated health systems, post-acute providers, and payer organizations.
What Industry Does NRC Operate In?
National Research Corporation operates within the healthcare information services industry, which is experiencing growth driven by the increasing emphasis on patient-centered care and the need for data-driven decision-making. The market is competitive, with various players offering analytics and insights solutions. NRC differentiates itself through its focus on patient and employee experience, providing specialized solutions tailored to healthcare organizations. The industry is expected to continue growing as healthcare providers seek to improve outcomes, reduce costs, and enhance patient satisfaction.
Who Are NRC's Key Customers?
- Integrated health systems
- Post-acute providers
- Payer organizations
Net buyingInsider Activity
Over the past six months, National Research Corporation insiders filed 4 SEC Form 4 transactions — 0 sales and 4 purchases. On net that is roughly 86K shares acquired (about $486K) — insiders putting money in tends to read as conviction.
NRC Valuation & Market Position
With a $507.98M market cap, National Research Corporation sits in the small-cap segment of the market. Relative to its peer group, NRC's quantitative score of 69/100 is roughly in line with the peer average of 67/100.
ROE 57%Key Financial Metrics
Return on equity for National Research Corporation stands at 57.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.7%, showing how much profit it generates from its asset base. NRC trades at a trailing price-to-earnings ratio of 44.71, above the Healthcare sector average of ~23x. Its free cash flow yield is 4.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.52 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 2.2%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
National Research Corporation's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.66 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project National Research Corporation revenue of about $118.3M for fiscal 2026, with EPS near $0.88.
Company Profile
National Research Corporation operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Lincoln, US. The company is led by CEO Trent Green. NRC has traded publicly since 2013.
NRC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in NRC's growth potential, indicating management's belief in future performance.
- Community sentiment has shifted positively, with discussions highlighting NRC's strong position in the healthcare analytics sector.
- Analysts are noting an increasing demand for patient experience solutions, which aligns with NRC's service offerings and market strategy.
- The company has been expanding its partnerships, enhancing its market reach and reinforcing its competitive edge.
Bear Case
- Concerns have emerged regarding potential regulatory changes that could impact NRC's business model and revenue streams.
- Recent earnings reports have shown slower growth compared to industry peers, raising questions about its market positioning.
- Social sentiment has revealed some skepticism about NRC's ability to innovate quickly enough in a rapidly evolving market.
- There are rising competitive pressures from new entrants in the healthcare analytics space, which could erode NRC's market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
NRC Latest News
-
Georgia's Plant Hatch receives 20-year license renewal from the Nuclear Regulatory Commission
prnewswire.com · Jun 15, 2026
-
NRC Health and Healthcare Experience Foundation Launch Strategic Partnership to Deepen Support for Improving Experience, Safety, and Workforce Engagement
gurufocus.com · Jun 9, 2026
-
Hadron Energy Announces NRC Acceptance of Quality Assurance Program Description for Future Manufacturing License Applications, a First for a Light-Water Microreactor
gurufocus.com · Jun 4, 2026
-
The Governance Institute Announces Blue Ribbon Committee on Health System Governance
Yahoo! Finance: NRC News · May 28, 2026
NRC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NRC.
Price Targets
Wall Street price target analysis for NRC.
NRC MoonshotScore
What does this score mean?
The MoonshotScore rates NRC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Georgia's Plant Hatch receives 20-year license renewal from the Nuclear Regulatory Commission
NRC Health and Healthcare Experience Foundation Launch Strategic Partnership to Deepen Support for Improving Experience, Safety, and Workforce Engagement
Hadron Energy Announces NRC Acceptance of Quality Assurance Program Description for Future Manufacturing License Applications, a First for a Light-Water Microreactor
The Governance Institute Announces Blue Ribbon Committee on Health System Governance
Leadership: Trent Green
CEO
Trent Green currently serves as the CEO of National Research Corporation. Information regarding his detailed career history, education, and previous roles is not available in the provided source data. Therefore, a comprehensive background profile cannot be constructed at this time.
Track Record: Information regarding Trent Green's specific achievements, strategic decisions, and company milestones under his leadership is not available in the provided source data. Therefore, a detailed track record cannot be provided at this time.
What Investors Ask About National Research Corporation (NRC) — Healthcare
What does National Research Corporation do?
National Research Corporation (NRC) provides analytics and insights to healthcare organizations in the United States and Canada. The company offers subscription-based solutions that help healthcare providers measure and enhance patient and employee experiences. These solutions cover a range of areas, including patient satisfaction, employee engagement, health risk assessments, and care transitions. By providing actionable data and analysis, NRC enables healthcare organizations to make informed decisions and improve outcomes.
What do analysts say about NRC stock?
Analyst opinions on National Research Corporation (NRC) stock are not available within the provided source data. Therefore, a summary of analyst consensus, key valuation metrics, and growth considerations cannot be provided. Investors should consult independent research reports and financial analysis platforms for up-to-date analyst ratings and price targets.
What are the main risks for NRC?
National Research Corporation (NRC) faces several risks, including intense competition from larger and more established players in the healthcare analytics market. Changes in healthcare regulations and reimbursement models could also impact demand for NRC's solutions. An economic downturn may reduce healthcare spending and affect client budgets. Additionally, rapid technological advancements may render existing solutions obsolete, requiring ongoing investment in research and development.
What are the key factors to evaluate for NRC?
National Research Corporation (NRC) holds an AI score of 69/100 (moderate). P/E: 44.7x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does NRC data refresh on this page?
NRC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NRC's recent stock price performance?
National Research Corporation (NRC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established presence in the healthcare analytics market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NRC overvalued or undervalued right now?
National Research Corporation (NRC) trades at 44.7x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NRC?
Before investing in National Research Corporation (NRC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based solely on the provided source data.
- CEO tenure data is unavailable.